ADAGENE INCORPORATION revenue breakdown overview

ADAGENE INCORPORATION revenue for the last year amounted to 99.69 k EUR, the most of which — 99.69 k EUR — came from its highest performing source at the moment, Monoclonal Antibody Drugs, the year earlier bringing 16.41 M EUR. The greatest contribution to the revenue figure was made by China — last year it brought ADAGENE INCORPORATION 99.69 k EUR, and the year before that — 16.41 M EUR.